<DOC>
	<DOCNO>NCT02681042</DOCNO>
	<brief_summary>The study cohort consist 50 patient candidate Left Atrial Appendage ( LAA ) closure oral anticoagulation contraindicate . Subjects evaluate left atrial appendage closure screen inclusion consent prior procedure . If anatomy favorable placement Lariat® device , procedure perform one participating center . If anatomy favorable , patient exclude study manage use best care practice physician .</brief_summary>
	<brief_title>Left Atrial Appendage Closure With SentreHeart Lariat® Device</brief_title>
	<detailed_description>The study cohort consist 50 patient candidate LAA closure oral anticoagulation contraindicate . Subjects evaluate left atrial appendage closure screen inclusion consent prior procedure . If anatomy favorable placement Lariat® device , procedure perform one participating center . If anatomy favorable , patient exclude study manage use best care practice physician . Subjects consent tracked study team consider enrol study time start leave atrial appendage closure procedure . All subject consent undergo leave atrial appendage closure SentreHeart Lariat® consider screen failure . Any patient fail attempt leave atrial appendage closure SentreHeart Lariat® track index hospitalization safety ; study follow complete time discharge . The invasive procedure placement study device proceed accord standard interventional technique , already place participate center . Patients undergo Lariat® procedure administer colchicine 0.6 mg po twice daily minimum three day preoperatively , 30 day postoperatively . ( This dose may adjust renal function intolerance ) . Patients undergo follow-up visit 7 day , 90 day , 180 day post procedure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients age ≥18 year Patients able willing provide inform consent Documentation atrial fibrillation atrial flutter Clinical decision subject 's physician patient risk embolic stroke , oral anticoagulant medication ( OAC ) contraindicate Hypertension , Abnormal renal hepatic function , Stroke , Bleeding tendency/predisposition , Labile International Normalized Ratios ( INRs ) warfarin ( HASBLED ) score &gt; 3 Congestive Heart Failure ( CHF ) , Hypertension , Age &gt; 65 , Diabetes Mellitus , Stroke Transient Ischemic Attack ( TIA ) , Vascular Disease , Age &gt; 75 , Sex Category ( CHADS2VASC ) score &gt; 3 , OR CHADS2VASC 2 physician provide justification procedure Anatomy favorable deployment SentreHeart Lariat® Medically unable provide inform consent Previous cardiothoracic surgery Patient candidate catheter surgical ablation Need concomitant cardiac surgery procedure Thrombus leave atrial appendage leave atrium Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>